Alcohol septal ablation after myomectomy failure solutions for unusual cases

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 5, 2010, Pages 719-723

  Cano, Manuel Nicolas ^a,b   De Cano, Silvia Judith Fortunato ^a   Sousa, J Eduardo M R ^a,b  

^a Hospital do Coracao   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

alcohol septal ablation; hypertrophic obstructive cardiomyopathy; myectomy

Indexed keywords

CONTRAST MEDIUM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROPRANOLOL;

ALCOHOL SEPTAL ABLATION; ARTICLE; BALLOON CATHETER; CASE REPORT; CATHETER ABLATION; CHILD; COLD CLAMMY SKIN; ELECTROCARDIOGRAPHY; FATIGUE; FOREIGN BODY REACTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE EJECTION; HISTOCOMPATIBILITY TEST; HUMAN; HYPERHIDROSIS; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; MITRAL VALVE REGURGITATION; MYOMECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; SCHOOL CHILD; SYSTOLIC HEART MURMUR; TRANSLUMINAL CORONARY ANGIOPLASTY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT FAILURE;

ABLATION TECHNIQUES; CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ELECTROCARDIOGRAPHY; ETHANOL; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; MALE; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; VENTRICULAR FUNCTION;

EID: 78349275000     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22539     Document Type: Article

References (20)

1. Maron BJ,. Hypertrophic cardiomyopathy: A systematic review. JAMA 2002; 287: 1308-1320.
2. Maron BJ, McKenna WJ, Danielson GK, et al. American college of cardiology/European society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American college of cardiology foundation task force on clinical expert consensus documents and the European society of cardiology committee for practice guidelines. J Am Coll Cardiol 2003; 42: 1687-1713.
3. Ommen SR, Maron BJ, Olivotto I, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 46: 470-476.
4. Sigwart U,. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995; 346: 211-214.
5. Decker JA, Rossano JW, Smith EO, et al. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. J Am Coll Cardiol 2009; 54: 250-254.
6. Minakata K, Dearani JA, O'Leary PW, et al. Septal myectomy for obstructive hypertrophic cardiomyopathy in pediatric patients: Early and late results. Ann Thorac Surg 2005; 80: 1424-1430.
7. Bradley BA, Edwards JM, Franks D,. Histocompatibility phenotyping by the mixed lymphocyte reaction. Tissue Antigens 2008; 5: 340-347.
8. Biagini E, Spirito P, Leone O, et al. Heart transplantation in hypertrophic cardiomyopathy. Am J Cardiol 2008; 101: 387-392.
9. Lammers AE, Roberts P, Brown KL, et al. Acute rejection after paediatric heart transplantation: Far less common and less severe. Transpl Int 2010; 23: 38-46.
10. Holmes DR, Valeti US, Nishimura RA,. Alcohol septal ablation for hypertrophic cardiomyopathy: Indications and technique. Catheter Cardiovasc Interv 2005; 66: 375-389.
11. Singh H, Kalra R, Keshavamurthy GB, et al. Percutaneous transluminal septal myocardial ablation in a child with hypertrophic obstructive cardiomyopathy and Noonan syndrome. Congenit Heart Dis 2008; 3: 347-351.
12. Veselka J, Zemánek D, Tomasov P, et al. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective. Heart Vessels 2009; 24: 27-31.
13. Kuhn H, Lawrenz T, Lieder F, et al. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): A 10 year experience. Clin Res Cardiol 2008; 97: 234-243.
14. Yetman AT, McCrindle BW,. Management of pediatric hypertrophic cardiomyopathy. Curr Opin Cardiol 2005; 20: 80-83.
15. Seggewiss H, Rigopoulos A,. Management of hypertrophic cardiomyopathy in children. Paediatr Drugs 2003; 5: 663-672.
16. Emmel M, Sreeram N, de Giovanni JV, et al. Radiofrequency catheter septal ablation for hypertrophic obstructive cardiomyopathy in childhood. Z Kardiol 2005; 94: 699-703.
17. Colan SD, Lipshultz SE, Lowe AM, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: Findings from the Pediatric Cardiomyopathy Registry. Circulation 2007; 115: 773-781.
18. Riera AR, de Cano SJ, Cano MN, et al. Vector electrocardiographic alterations after percutaneous septal ablation in obstructive hypertrophic cardiomyopathy. Possible anatomic causes. Arq Bras Cardiol 2002; 79: 466-475.
19. Ommen SR, Shah PM, Tajik AJ,. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: Past, present and future. Heart 2008; 94: 1276-1281.
20. Maron BJ, Maron MS, Wigle ED, et al. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: From idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. J Am Coll Cardiol 2009; 54: 191-200.